General Information of the Cell Line
Cell Line ID
CL000431
Cell Line Name
SNU-16
Synonyms
SNU16
NCI-SNU-16
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0076
Tissue Information
Ascites
Disease
Gastric adenocarcinoma (NCIt: C4004)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01115, Fibroblast growth factor receptor 2
Compound ID Compound Name Compound Formula
CP0236837
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-[(3R,5S)-3,4,5-trimethylpiperazin-1-yl]quinazolin-4-amine
   Show/Hide
C28H35N7O2
 1
1
IC50 < 0.1 nM
   TI
   LI
   LO
   TS
CP0549218
7-(4-cyclobutylpiperazin-1-yl)-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]quinazolin-4-amine
   Show/Hide
C29H35N7O2
 1
1
IC50 < 0.1 nM
   TI
   LI
   LO
   TS
CP0569655
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-(4-propan-2-ylpiperazin-1-yl)quinazolin-4-amine
   Show/Hide
C28H35N7O2
 1
1
IC50 < 0.1 nM
   TI
   LI
   LO
   TS
CP0761938
N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-7-(4-methylpiperazin-1-yl)quinazolin-4-amine
   Show/Hide
C26H31N7O2
 1
1
IC50 = 0.7 nM
   TI
   LI
   LO
   TS
CP0047214
7-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]quinazolin-4-amine
   Show/Hide
C29H35N7O2
 1
1
IC50 = 0.8 nM
   TI
   LI
   LO
   TS
CP0122169
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-(4-ethylpiperazin-1-yl)quinazolin-4-amine
   Show/Hide
C27H33N7O2
 1
1
IC50 = 1.2 nM
   TI
   LI
   LO
   TS
CP0549217
N-[5-[2-(2,6-dichloro-3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-(4-ethylpiperazin-1-yl)quinazolin-4-amine
   Show/Hide
C27H31Cl2N7O2
 1
1
IC50 = 1.4 nM
   TI
   LI
   LO
   TS
CP0047221
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-6-(4-ethylpiperazin-1-yl)isoquinolin-1-amine
   Show/Hide
C28H34N6O2
 1
1
IC50 = 1.8 nM
   TI
   LI
   LO
   TS
CP0054573
CHEBI:63453
   Show/Hide
C26H33N5O3
 2
1
IC50 = 3.6 nM
   TI
   LI
   LO
   TS
2
IC50 = 25.4 nM
   TI
   LI
   LO
   TS
CP0047213
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-morpholin-4-ylquinazolin-4-amine
   Show/Hide
C25H28N6O3
 1
1
IC50 = 3.9 nM
   TI
   LI
   LO
   TS
CP0121917
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-(1-methylpiperidin-4-yl)quinazolin-4-amine
   Show/Hide
C27H32N6O2
 1
1
IC50 = 9 nM
   TI
   LI
   LO
   TS
CP0121918
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-[3-(dimethylamino)pyrrolidin-1-yl]quinazolin-4-amine
   Show/Hide
C27H33N7O2
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0090815
4-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-N-(2-methoxyethyl)quinazoline-4,7-diamine
   Show/Hide
C24H28N6O3
 1
1
IC50 = 10.3 nM
   TI
   LI
   LO
   TS
CP0569656
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine
   Show/Hide
C27H33N7O2
 1
1
IC50 = 10.8 nM
   TI
   LI
   LO
   TS
CP0462436
4-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-N-(2-morpholin-4-ylethyl)quinazoline-4,7-diamine
   Show/Hide
C27H33N7O3
 1
1
IC50 = 13.2 nM
   TI
   LI
   LO
   TS
CP0690841
N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-8-(4-ethylpiperazin-1-yl)quinazolin-4-amine
   Show/Hide
C27H33N7O2
 1
1
IC50 = 13.8 nM
   TI
   LI
   LO
   TS
CP0360545
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-[4-(dimethylamino)piperidin-1-yl]quinazolin-4-amine
   Show/Hide
C28H35N7O2
 1
1
IC50 = 17.5 nM
   TI
   LI
   LO
   TS
CP0182382
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-2-ethyl-7-(4-ethylpiperazin-1-yl)quinazolin-4-amine
   Show/Hide
C29H37N7O2
 1
1
IC50 = 24.7 nM
   TI
   LI
   LO
   TS
CP0081362
4-fluoro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol
   Show/Hide
C27H23FN4O2
 1
1
IC50 = 24.8 nM
   TI
   LI
   LO
   TS
CP0081381
4-chloro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol
   Show/Hide
C27H23ClN4O2
 1
1
IC50 = 24.8 nM
   TI
   LI
   LO
   TS
CP0099316
3-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol
   Show/Hide
C27H24N4O2
 1
1
IC50 = 36.2 nM
   TI
   LI
   LO
   TS
CP0099314
2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol
   Show/Hide
C27H24N4O2
 1
1
IC50 = 57.5 nM
   TI
   LI
   LO
   TS
CP0133097
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-(4-ethylpiperazin-1-yl)-2-propylquinazolin-4-amine
   Show/Hide
C30H39N7O2
 1
1
IC50 = 90 nM
   TI
   LI
   LO
   TS
CP0047216
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-(4-ethylpiperazin-1-yl)-2-methylquinazolin-4-amine
   Show/Hide
C28H35N7O2
 1
1
IC50 = 105.7 nM
   TI
   LI
   LO
   TS
CP0569659
2-chloro-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-(4-ethylpiperazin-1-yl)quinazolin-4-amine
   Show/Hide
C27H32ClN7O2
 1
1
IC50 = 108.2 nM
   TI
   LI
   LO
   TS
CP0081678
4-chloro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-isoquinolin-6-ylpyridin-2-yl]phenol
   Show/Hide
C28H22ClN3O2
 1
1
IC50 = 249 nM
   TI
   LI
   LO
   TS
CP0118716
2,4-difluoro-6-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol
   Show/Hide
C27H22F2N4O2
 1
1
IC50 = 280.1 nM
   TI
   LI
   LO
   TS
CP0109337
4,5-difluoro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol
   Show/Hide
C27H22F2N4O2
 1
1
IC50 = 288.6 nM
   TI
   LI
   LO
   TS
CP0118715
2-fluoro-6-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol
   Show/Hide
C27H23FN4O2
 1
1
IC50 = 293.5 nM
   TI
   LI
   LO
   TS
CP0109346
5-fluoro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol
   Show/Hide
C27H23FN4O2
 1
1
IC50 = 313.3 nM
   TI
   LI
   LO
   TS
CP0109448
(2R)-2-[[5-(3-methyl-2H-indazol-5-yl)-6-phenylpyridin-3-yl]amino]-2-phenylethanol
   Show/Hide
C27H24N4O
 1
1
IC50 = 677.7 nM
   TI
   LI
   LO
   TS
CP0234743
4-chloro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-2-yl]phenol
   Show/Hide
C26H22ClN5O2
 1
1
IC50 = 2281.3 nM
   TI
   LI
   LO
   TS
CP0121920
4-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-(4-ethylpiperazin-1-yl)-2-N-[(3-methyl-1,2-oxazol-5-yl)methyl]quinazoline-2,4-diamine
   Show/Hide
C32H39N9O3
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0653199
N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)quinazolin-4-amine
   Show/Hide
C21H21N5O2
 1
1
IC50 > 200 nM
   TI
   LI
   LO
   TS
CP0717956
5-Chloro-N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)quinazolin-4-amine
   Show/Hide
C21H20ClN5O2
 1
1
IC50 > 200 nM
   TI
   LI
   LO
   TS
CP0734490
N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-8-methoxyquinazolin-4-amine
   Show/Hide
C22H23N5O3
 1
1
IC50 > 200 nM
   TI
   LI
   LO
   TS
CP0734491
8-Chloro-N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)quinazolin-4-amine
   Show/Hide
C21H20ClN5O2
 1
1
IC50 > 200 nM
   TI
   LI
   LO
   TS
CP0961526
N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-5-methoxyquinazolin-4-amine
   Show/Hide
C22H23N5O3
 1
1
IC50 > 200 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0548604
7-[N-(cyclopropylmethyl)-3,5-dimethoxyanilino]-3-(1-methylpyrazol-4-yl)pyrido[1,2-a]pyrimidin-4-one
   Show/Hide
C24H25N5O3  1
1
IC50 = 3.1 nM
   TI
   LI
   LO
   TS
CP0549253
3-[1-(1-acetylazetidin-3-yl)pyrazol-4-yl]-7-[3,5-dimethoxy-N-[2-(propan-2-ylamino)ethyl]anilino]pyrido[1,2-a]pyrimidin-4-one
   Show/Hide
C29H35N7O4  1
1
IC50 = 4.4 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Ascites)
Cell Line Name Organism Disease
PEO1 Homo sapiens (Human) BRCA2-associated hereditary breast and ovarian cancer syndrome
MAST Homo sapiens (Human) Breast carcinoma
Ramos Homo sapiens (Human) Burkitt lymphoma
CA46 Homo sapiens (Human) Burkitt lymphoma
CellSensor STAT6-bla RA-1 Homo sapiens (Human) Burkitt lymphoma
NCI-H716 Homo sapiens (Human) Cecum adenocarcinoma
COLO 205 Homo sapiens (Human) Colon adenocarcinoma
COLO 201 Homo sapiens (Human) Colon adenocarcinoma
DiFi Homo sapiens (Human) Colorectal carcinoma
U-2932 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
DB Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
HEC-50B Homo sapiens (Human) Endometrial adenocarcinoma
SNU-5 Homo sapiens (Human) Gastric adenocarcinoma
SNU-620 Homo sapiens (Human) Gastric adenocarcinoma
SNU-638 Homo sapiens (Human) Gastric adenocarcinoma
SNU-668 Homo sapiens (Human) Gastric signet ring cell adenocarcinoma
OVCAR-3 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
OVCAR-5 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
COV318 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
ZR-75-1 Homo sapiens (Human) Invasive breast carcinoma of no special type
SK-HEP-1 Homo sapiens (Human) Liver and intrahepatic bile duct epithelial neoplasm
OV-90 Homo sapiens (Human) Ovarian adenocarcinoma
LK2 Homo sapiens (Human) Ovarian carcinoma
RMG-I Homo sapiens (Human) Ovarian clear cell adenocarcinoma
PA-1 Homo sapiens (Human) Ovarian mixed germ cell tumor
SK-OV-3 Homo sapiens (Human) Ovarian serous cystadenocarcinoma
SKOV3/TR Homo sapiens (Human) Ovarian serous cystadenocarcinoma
AsPC-1 Homo sapiens (Human) Pancreatic ductal adenocarcinoma
HEC Homo sapiens (Human) Peritoneal malignant mesothelioma
Ehrlich-Lettre ascites strain E Mus musculus (Mouse) Malignant neoplasms of the mouse mammary gland
RAW 264.7 Mus musculus (Mouse) Mouse leukemia
L1210 Mus musculus (Mouse) Mouse leukemia
L1210/R81 Mus musculus (Mouse) Mouse leukemia
RAW-Lucia ISG Mus musculus (Mouse) Mouse leukemia
RAW-Lucia ISG-KO-STING Mus musculus (Mouse) Mouse leukemia
RAW 264 Mus musculus (Mouse) Mouse leukemia
J774 Mus musculus (Mouse) Mouse reticulum cell sarcoma
J774A1 Mus musculus (Mouse) Mouse reticulum cell sarcoma
HTC Rattus norvegicus (Rat) Rat hepatocellular carcinoma